Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 15Other neoplasm 1Other 1

Conditions

Mucositis 8Head and Neck Neoplasms 6Squamous Cell Carcinoma of Head and Neck 4Xerostomia 3Stomatitis 2Radiation Injuries 2Mouth Neoplasms 2Tongue Neoplasms 1Pain 1Neoplasms 1Chemotherapy-induced Peripheral Neuropathy 1Carcinoma, Squamous Cell 1

Interventions

Vaccinium myrtillus extract 1Radiotherapy, Intensity-Modulated 1Doxepin 1Cisplatin 1CBLB502 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Tongue Neoplasms × Cisplatin × Other × Clear all
NCT01728480 2013-12-11

Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy

Roswell Park Cancer Institute

Phase 1 Withdrawn
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡